Sign inJoin
Company / Finance

IDEXX Laboratories, Inc.

IDXX · NASDAQ

IDEXX reported FY2025 revenue of $4.3 billion and Q1 2026 revenue of $1.1 billion. The thesis depends on companion-animal diagnostics demand, instrument placement, consumables pull-through, margin durability and cash conversion.

FollowAdd to WatchlistAsk Question
NASDAQIDXXCoverage BootstrapIDEXX Laboratories, Inc.
Latest ReportMay 20, 2026IDXX: Veterinary diagnostics quality has to keep converting into cashView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 company reports
Latest Thesis

IDXX: Veterinary diagnostics quality has to keep converting into cash

IDEXX reported FY2025 revenue of $4.3 billion and Q1 2026 revenue of $1.1 billion. The thesis depends on companion-animal diagnostics demand, instrument placement, consumables pull-through, margin durability and cash conversion.

May 20, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
IDEXX Laboratories, Inc.Veterinary diagnostics quality has to keep converting into cashMay 20, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
IDXX: Veterinary diagnostics quality has to keep converting into cashIDEXX reported FY2025 revenue of $4.3 billion and Q1 2026 revenue of $1.1 billion. The thesis depends on companion-animal diagnostics demand, instrument placement, consumables pull-through, margin durability and cash conversion.NASDAQMay 20, 2026Research reportReadSlides